Literature DB >> 1103687

Incorporation of analog purine nucleosides into the formed elements of human blood: erythrocytes, platelets, and lymphocytes.

R E Parks, G W Crabtree, C M Kong, R P Agarwal, K C Agarwal, E M Scholar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1103687     DOI： 10.1111/j.1749-6632.1975.tb29249.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  15 in total

1.  Activities and some properties of 5'-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine.

Authors:  J R Arch; E A Newsholme
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

2.  Metabolism of 2',3'-dideoxyinosine (ddI) in human blood.

Authors:  D J Back; S Ormesher; J F Tjia; R Macleod
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

3.  Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  R P Agarwal; G W Crabtree; R E Parks; J A Nelson; R Keightley; R Parkman; F S Rosen; R C Stern; S H Polmar
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

4.  The erythrocyte as instigator of inflammation. Generation of amidated C3 by erythrocyte adenosine deaminase.

Authors:  M K Hostetter; G M Johnson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

5.  Evaluation of a common receptor-complement concept for predicting the antileukemic activity of nucleosides.

Authors:  L B Townsend; K H Schram; J Beránek
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

6.  Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.

Authors:  D Singhal; M E Morgan; B D Anderson
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

7.  Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors.

Authors:  William B Parker; Eric J Sorscher
Journal:  Curr Pharm Des       Date:  2017-11-08       Impact factor: 3.116

8.  In vitro of adenosine on lymphocytes and erythrocytes from horses with combined immunodeficiency.

Authors:  N S Magnuson; L E Perryman
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

9.  The accumulation of mercaptopurine metabolites in age fractionated red blood cells.

Authors:  A Rostami-Hodjegan; L Lennard; J S Lilleyman
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

10.  IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.

Authors:  Sofie Haglund; Jan Taipalensuu; Curt Peterson; Sven Almer
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.